Johnson & Johnson vaccine recommended for Canadians 30 and older despite risk of rare blood clots


The Johnson & Johnson vaccine is now recommended for all Canadians 30 years of age and older, but officials say to weigh the risk of rare but potentially serious blood clots that can occur from the vaccine against COVID-19 levels in the community — or hold out for another shot altogether.

Leave a Reply

Your email address will not be published. Required fields are marked *